On November 17, 2022, in connection with the Seed Commitment, the Seed Vehicle paid approximately $285,714 to purchase approximately 11,428.57 Class I Shares at $25.00 per Share (the “November 17, 2022 Investment”).
On November 29, 2022, in connection with the Seed Commitment, the Seed Vehicle paid approximately $285,714 to purchase approximately 11,428.57 Class I Shares at $25.00 per Share (the “November 29, 2022 Investment” and, together with the November 17, 2022 Investment, the “November 2022 Investments”).
On December 15, 2022, in connection with the Seed Commitment, the Seed Vehicle paid approximately $142,857 to purchase approximately 5,714.29 Class I Shares at $25.00 per Share (the “December 15, 2022 Investment”).
On December 19, 2022, in connection with the Seed Commitment, the Seed Vehicle paid approximately $142,857 to purchase approximately 5,714.29 Class I Shares at $25.00 per Share (the “December 19, 2022 Investment” and, together with the December 15, 2022 Investment, the “December 2022 Investments”).
On February 14, 2023, in connection with the Seed Commitment, the Seed Vehicle paid approximately $285,714 to purchase approximately 11,428.57 Class I Shares at $25.00 per Share (the “February 2023 Investment”).
On March 27, 2023, in connection with the Seed Commitment, the Seed Vehicle paid approximately $2,285,714 to purchase approximately 91,428.57 Class I Shares at $25.00 per Share (the “March 2023 Investment”).
On May 30, 2023, in connection with the Seed Commitment, the Seed Vehicle paid approximately $285,714 to purchase approximately 10,925.98 Class I Shares at $26.15 per Share (the “May 2023 Investment” and, together with the July 2022 Investment, the August 2022 Investment, the October 2022 Investment, the November 2022 Investments, the December 2022 Investments, the February 2023 Investment and the March 2023 Investment, the “Investments”).
Under the terms of the Fund’s declaration of trust (as amended and restated from time to time), all Shares have equal rights as to voting. Except as may be provided by the Fund’s Board of Trustees (the “Board”) in setting the terms of classified or reclassified shares, the Shares have no preemptive, exchange, conversion, appraisal or redemption rights. In the event of the Fund’s liquidation, dissolution or winding up, each Share would be entitled to share pro rata in all of the Fund’s assets that are legally available for distribution after it pays all debts and other liabilities and subject to any preferential rights of holders of the Fund’s preferred shares, if any preferred shares are outstanding at such time. Subject to the rights of holders of any other class or series of shares, each Share will be entitled to one vote on all matters submitted to a vote of shareholders, including the election of trustees. Except as may be provided by the Board in setting the terms of classified or reclassified shares, and subject to the express terms of any class or series of preferred shares, the holders of the Shares will possess exclusive voting power. There is no cumulative voting in the election of the Fund’s trustees. Subject to the special rights of the holders of any class or series of preferred shares to elect trustees, each trustee of the Fund will be elected by a plurality of the votes cast with respect to such trustee’s election.
The Investments were paid from working capital of FSH.
Item 4. | Purpose of Transaction. |
FSH directly (and indirectly through the Seed Vehicle) made the Seed Commitment and Investments in order to provide the Fund with sufficient capital to establish an initial portfolio of investments and, as the ultimate parent company of one of the joint owners and operators of the Fund’s investment adviser, to demonstrate the alignment of its interests with those of Fund shareholders.
The descriptions of the contributions and the transactions contained in Item 3 are hereby incorporated by reference into this Item 4.
Mr. Forman is the Chairman and chief executive officer of FSH, serves as Chairman and chief executive officer of the Fund and serves as Chairman, president and/or chief executive officer of certain of the firm’s other funds and affiliated investment advisers. Mr. Adelman is one of the founders of FSH and is the Vice Chairman of FSH. FSH is